Abstract

Aim. The study aims to assess the degree of significance of the triglyceride-glucose (TyG) index in the diagnosis of erectile function. Materials and Methods. The study involved 120 patients examined from 2021 to 2022 at the Federal State Budgetary Institution State Scientific Center FMBC named after A.I. Burnazyan FMBA of Russia. Patients filled out the International Index of Erectile Function scale, and the TyG index was calculated. The patients were divided into two groups: Group 1 comprised patients with mild and moderate severity of erectile dysfunction (ED) (n=60), while Group 2 included patients not clinically manifesting ED (reference group) (n=60). The TyG index was analyzed in both groups to determine its relationship with ED. Results. The analysis revealed that the risk of developing ED occurs when the TyG index value exceeds 4.49. Increasing the threshold level to 5.0 was found to be nonsignificant. A TyG index value exceeding 4.49 corresponded to an odds ratio of 114.0 (95% CI 13.7-947.7, z=4.383, p<0.0001), making it a reference value for determining the risk of ED. Conclusions. Currently, widely available methods for diagnosing and assessing the risk of ED, including for treatment decisions, are lacking. The triglyceride/glucose (TyG) index has the potential to serve as a quick and accessible test for this purpose.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call